210 related articles for article (PubMed ID: 16327184)
1. Development of fast disintegrating compressed tablets using amino acid as disintegration accelerator: evaluation of wetting and disintegration of tablet on the basis of surface free energy.
Fukami J; Ozawa A; Yoshihashi Y; Yonemochi E; Terada K
Chem Pharm Bull (Tokyo); 2005 Dec; 53(12):1536-9. PubMed ID: 16327184
[TBL] [Abstract][Full Text] [Related]
2. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity.
Bi Y; Sunada H; Yonezawa Y; Danjo K; Otsuka A; Iida K
Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2121-7. PubMed ID: 8945778
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose.
Fukami J; Yonemochi E; Yoshihashi Y; Terada K
Int J Pharm; 2006 Mar; 310(1-2):101-9. PubMed ID: 16434157
[TBL] [Abstract][Full Text] [Related]
4. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
[TBL] [Abstract][Full Text] [Related]
5. Evaluation about wettability, water absorption or swelling of excipients through various methods and the correlation between these parameters and tablet disintegration.
Yang B; Wei C; Yang Y; Wang Q; Li S
Drug Dev Ind Pharm; 2018 Sep; 44(9):1417-1425. PubMed ID: 29557692
[TBL] [Abstract][Full Text] [Related]
6. Fast-disintegrating sublingual tablets: effect of epinephrine load on tablet characteristics.
Rawas-Qalaji MM; Simons FE; Simons KJ
AAPS PharmSciTech; 2006 Apr; 7(2):E41. PubMed ID: 16796358
[TBL] [Abstract][Full Text] [Related]
7. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
Lin SY; Lin KH; Li MJ
J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the disintegration time of rapidly disintegrating tablets via a novel method utilizing a CCD camera.
Morita Y; Tsushima Y; Yasui M; Termoz R; Ajioka J; Takayama K
Chem Pharm Bull (Tokyo); 2002 Sep; 50(9):1181-6. PubMed ID: 12237533
[TBL] [Abstract][Full Text] [Related]
9. Orally Disintegrating Tablet Manufacture via Direct Powder Compression Using Cellulose Nanofiber as a Functional Additive.
Nakamura S; Fukai T; Sakamoto T
AAPS PharmSciTech; 2021 Dec; 23(1):37. PubMed ID: 34950985
[TBL] [Abstract][Full Text] [Related]
10. Effect of the type of lubricant on the characteristics of orally disintegrating tablets manufactured using the phase transition of sugar alcohol.
Kuno Y; Kojima M; Nakagami H; Yonemochi E; Terada K
Eur J Pharm Biopharm; 2008 Aug; 69(3):986-92. PubMed ID: 18396020
[TBL] [Abstract][Full Text] [Related]
11. Formulation and characterisation of lyophilised rapid disintegrating tablets using amino acids as matrix forming agents.
AlHusban F; Perrie Y; Mohammed AR
Eur J Pharm Biopharm; 2010 Jun; 75(2):254-62. PubMed ID: 20332027
[TBL] [Abstract][Full Text] [Related]
12. Effects of disintegration-promoting agent, lubricants and moisture treatment on optimized fast disintegrating tablets.
Late SG; Yu YY; Banga AK
Int J Pharm; 2009 Jan; 365(1-2):4-11. PubMed ID: 18778759
[TBL] [Abstract][Full Text] [Related]
13. Disintegration propensity of tablets evaluated by means of disintegrating force kinetics.
Massimo G; Catellani PL; Santi P; Bettini R; Vaona G; Bonfanti A; Maggi L; Colombo P
Pharm Dev Technol; 2000; 5(2):163-9. PubMed ID: 10810746
[TBL] [Abstract][Full Text] [Related]
14. Direct compression of cushion-layered ethyl cellulose-coated extended release pellets into rapidly disintegrating tablets without changes in the release profile.
Hosseini A; Körber M; Bodmeier R
Int J Pharm; 2013 Dec; 457(2):503-9. PubMed ID: 23892153
[TBL] [Abstract][Full Text] [Related]
15. Development of oral dosage form for elderly patients: use of agar as base of rapidly disintegrating oral tablets.
Ito A; Sugihara M
Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2132-6. PubMed ID: 8945779
[TBL] [Abstract][Full Text] [Related]
16. The role of formulation excipients in the development of lyophilised fast-disintegrating tablets.
Chandrasekhar R; Hassan Z; Alhusban F; Smith AM; Mohammed AR
Eur J Pharm Biopharm; 2009 May; 72(1):119-29. PubMed ID: 19073253
[TBL] [Abstract][Full Text] [Related]
17. [Establishment of a Novel Method to Evaluate Water Permeation Rates by Combining the Dynamic Contact Angle and Thermographic Approach: Significance of Disintegration Properties of Orally Disintegrating Tablets].
Suzuki T; Kurano T; Kanazawa T; Suzuki N
Yakugaku Zasshi; 2020; 140(8):1071-1080. PubMed ID: 32741865
[TBL] [Abstract][Full Text] [Related]
18. Development of novel fast-disintegrating tablets by direct compression using sucrose stearic acid ester as a disintegration-accelerating agent.
Koseki T; Onishi H; Takahashi Y; Uchida M; Machida Y
Chem Pharm Bull (Tokyo); 2008 Oct; 56(10):1384-8. PubMed ID: 18827375
[TBL] [Abstract][Full Text] [Related]
19. Preparation and optimization of mouth/orally dissolving tablets using a combination of glycine, carboxymethyl cellulose and sodium alginate: a comparison with superdisintegrants.
Vora N; Rana V
Pharm Dev Technol; 2008; 13(3):233-43. PubMed ID: 18484492
[TBL] [Abstract][Full Text] [Related]
20. Formulation, development, and performance evaluation of metoclopramide HCl oro-dispersible sustained release tablet.
Kasliwal N; Negi JS; Jugran V; Jain R
Arch Pharm Res; 2011 Oct; 34(10):1691-700. PubMed ID: 22076769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
